Aimei Health Stock Sees 1,000% Surge Before Crashing Amid SPAC Deadline Extension
Aimei Health Technology's stock (AFJK) experienced extreme volatility this week, skyrocketing 1,006% on Tuesday before plunging 44% in after-hours trading Wednesday. The wild price action coincided with the SPAC's 13th extension of its merger deadline with Chinese hydrogen firm United Hydrogen Group, now pushed to December 2026.
The company deposited $34,330.96 into its trust account to fund the extension, split equally between both parties. Despite the rollercoaster movement, AFJK shares remain up 724.79% year-to-date—a testament to the speculative frenzy surrounding SPAC deals in current markets.
Market observers note the extension payment was structured through an unsecured promissory note convertible to private shares post-merger, adding another LAYER of complexity to this already volatile play.
